Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma. — المؤلف: Chari, Ajai — Cancer 20190911

المؤلف
Chari, Ajai
النشر
Cancer 20190911
الوصف
4342-4349 p.
الموضوعات
Acetates؛ Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal؛ Antineoplastic Agents, Immunological؛ Cyclopropanes؛ Drug Administration Schedule